Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rank in Stocks #27024
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Share Price
$0.16240909
Last synced: 2025-03-04
Market Cap
$35.68M
Change (1 day)
0.27%
Change (1 year)
0.00%
Country
CN
Trade Dali Pharmaceuticalco.,Ltd (603963)

Category

Revenue for Dali Pharmaceuticalco.,Ltd (603963)
Revenue in Sep 2024 TTM: $8.60M
According to Dali Pharmaceuticalco.,Ltd latest financial reports the company's current revenue (TTM) is $8.60M. In 2022 the company made a revenue of $19.19M a decrease compared to the revenue in the year 2021 that was $26.98M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Dali Pharmaceuticalco.,Ltd from 2012 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $8.60M -30.22%
2023 $12.33M -35.74%
2022 $19.19M -28.89%
2021 $26.98M -17.47%
2020 $32.69M -22.65%
2019 $42.27M -27.58%
2018 $58.37M 39.23%
2017 $41.92M 5.54%
2016 $39.72M -3.39%
2015 $41.11M -24.82%
2014 $54.68M 11.43%
2013 $49.07M 7.27%
2012 $45.75M 0.00%
Revenue for similar companies or competitors